Artelo Biosciences, Inc. · NASDAQ:ARTL
Artelo Biosciences, Inc. shareholders
As of Jun 30, 2026, 9 institutions reported holding Artelo Biosciences, Inc., 2.5% of its shares. Largest: Jane Street, Geode Capital and Vanguard. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Artelo Biosciences, Inc. | Change | Filed |
|---|---|---|---|---|
| Jane Street | 66,341 | 1.4% | +53,262 | Aug 14, 2026 |
| Geode Capital | 13,864 | 0.30% | new | Aug 12, 2026 |
| Vanguard | 13,268 | 0.29% | no change | Aug 13, 2026 |
| StoneX Group Inc. | 12,400 | 0.27% | new | Aug 12, 2026 |
| Tower Research Capital LLC (TRC) | 8,435 | 0.18% | +5,609 | Aug 11, 2026 |
| UBS | 2,804 | 0.06% | new | Aug 13, 2026 |
| TD | 2 | <0.01% | new | Jul 27, 2026 |
| Rothschild Investment LLC | 2 | <0.01% | no change | Aug 6, 2026 |
| Danske Bank A/S | 1 | <0.01% | new | Aug 10, 2026 |